Tom 4, Nr 4 (2023)
Artykuł przeglądowy
Opublikowany online: 2024-02-12
Wyświetlenia strony 147
Wyświetlenia/pobrania artykułu 15
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Centralny bezdech senny — praktyczne aspekty dotyczące klasyfikacji i postępowania

Kinga Wszółkowska1, Natália Zsulinszka1, Aleksander Kania12
DOI: 10.5603/pp.98216
Pneum Pol 2023;4(4):135-144.

Streszczenie

Centralne zaburzenia oddychania w czasie snu są podstawowym kryterium rozpoznania centralnego bezdechu sennego (CBS). Rozpoznaje się go na podstawie badania snu i obrazu klinicznego. Zgodnie z Międzynarodową Klasyfikacją Zaburzeń Snu (ICSD, International Classification of Sleep Disorder) wyróżniamy: CBS związany z zespołem Cheyne’a–Stokesa, CBS związany z innymi chorobami, CBS spowodowany cyklicznym oddychaniem na dużej wysokości, CBS spowodowany przez leki lub inne substancje, pierwotny CBS, pierwotny CBS u niemowląt, pierwotny CBS u noworodków urodzonych przedwcześnie, CBS pojawiający się w trakcie leczenia wspomaganiem oddychania za pomocą dodatniego ciśnienia w drogach oddechowych. Leczenie powinno obejmować chorobę podstawową, która predysponuje do wystąpienia centralnych bezdechów w czasie snu, oraz obecne zaburzenia
oddychania.

Artykuł dostępny w formacie PDF

Dodaj do koszyka: 49,00 PLN

Posiadasz dostęp do tego artykułu?

Referencje

  1. American academy of sleep medicine. International classification of sleep disorders. 3rd ed. Darien, IL: American Academy of Sleep Medicine 2014.
  2. Riha RL, Celmina M, Cooper B, et al. ERS technical standards for using type III devices (limited channel studies) in the diagnosis of sleep disordered breathing in adults and children. Eur Respir J. 2023; 61(1).
  3. Bixler EO, Vgontzas AN, Ten Have T, et al. Effects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med. 1998; 157(1): 144–148.
  4. Donovan LM, Kapur VK. Prevalence and characteristics of central compared to obstructive sleep apnea: analyses from the sleep heart health study cohort. Sleep. 2016; 39(7): 1353–1359.
  5. Pływaczewski R, Bednarek M, Jonczak L, et al. Sleep-disordered breathing in a middle-aged and older polish urban population. J Sleep Res. 2008; 17(1): 73–81.
  6. Kuczyński W, Kudrycka A, Małolepsza A, et al. The epidemiology of obstructive sleep apnea in poland—polysomnography and positive airway pressure therapy. Int J Environ Res Public Health. 2021; 18(4): 2109.
  7. Wellman A, Jordan A, Malhotra A, et al. Ventilatory control and airway anatomy in obstructive sleep apnea. Am J Respir Crit Care Med. 2004; 170(11): 1225–1232.
  8. Wellman A, Malhotra A, Jordan AS, et al. Chemical control stability in the elderly. J Physiol. 2007; 581(Pt 1): 291–298.
  9. Javaheri S. A mechanism of central sleep apnea in patients with heart failure. N Engl J Med. 1999; 341(13): 949–954.
  10. Dempsey J, Gibbons T. Rethinking O2, CO2 and breathing during wakefulness and sleep. The Journal of Physiology. 2023.
  11. Sunwoo BY, Mokhlesi B. Obesity hypoventilation syndrome: will early detection and effective therapy improve long-term outcomes? J Clin Sleep Med. 2018; 14(9): 1455–1457.
  12. Sunwoo BY, Schmickl CN, Malhotra A. Contemporary concise review 2019: sleep and ventilation. Respirology. 2020; 25(5): 552–558.
  13. D'Cruz RF, Murphy PB, Kaltsakas G. Sleep disordered breathing and chronic obstructive pulmonary disease: a narrative review on classification, pathophysiology and clinical outcomes. J Thorac Dis. 2020; 12(Suppl 2): S202–S216.
  14. Troester MM, Quan SF, Berry RB et al. For the american academy of sleep medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Version 3. Darien IL: american academy of sleep medicine; 2023. https://aasm.org/clinical-resources/scoring-manual/ (05.09.2023).
  15. MacDonald M, Fang J, Pittman SD, et al. The current prevalence of sleep disordered breathing in congestive heart failure patients treated with beta-blockers. J Clin Sleep Med. 2008; 4(1): 38–42.
  16. Schultz HD, Marcus NJ, Rio RD. Mechanisms of carotid body chemoreflex dysfunction during heart failure. Exp Physiol. 2015; 100(2): 124–129.
  17. Trinder J, Merson R, Rosenberg JI, et al. Pathophysiological interactions of ventilation, arousals, and blood pressure oscillations during cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med. 2000; 162(3 Pt 1): 808–813.
  18. Andreas S. Central sleep apnea and chronic heart failure. Sleep. 2000; 23: S220–S223.
  19. Parra O, Arboix A, Bechich S, et al. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med. 2000; 161(2 Pt 1): 375–380.
  20. Latshang TD, Lo Cascio CM, Stöwhas AC, et al. Are nocturnal breathing, sleep, and cognitive performance impaired at moderate altitude (1,630-2,590 m)? Sleep. 2013; 36(12): 1969–1976.
  21. Bloch KE, Latshang TD, Turk AJ, et al. Nocturnal periodic breathing during acclimatization at very high altitude at mount muztagh ata (7,546 m). Am J Respir Crit Care Med. 2010; 182(4): 562–568.
  22. Nussbaumer-Ochsner Y, Ursprung J, Siebenmann C, et al. Effect of short-term acclimatization to high altitude on sleep and nocturnal breathing. Sleep. 2012; 35(3): 419–423.
  23. Grimm M, Seglias A, Ziegler L, et al. Sleep apnea in school-age children living at high altitude. Pulmonology. 2023; 29(5): 385–391.
  24. Tan Lu, Li T, Luo L, et al. The characteristics of sleep apnea in tibetans and han long-term high altitude residents. Nat Sci Sleep. 2022; 14: 1533–1544.
  25. Walker JM, Farney RJ, Rhondeau SM, et al. Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing. J Clin Sleep Med. 2007; 03(05): 455–461.
  26. Webster L, Choi Y, Desai H, et al. Sleep-Disordered breathing and chronic opioid therapy. Pain Med. 2008; 9(4): 425–432.
  27. Ahmad B, Sankari A, Eshraghi M, et al. Effect of zolpidem on nocturnal arousals and susceptibility to central sleep apnea. Sleep Breath. 2022; 27(1): 173–180.
  28. Xie A, Wong B, Phillipson EA, et al. Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med. 1994; 150(2): 489–495.
  29. Levin J, Jang J, Rhein L. Apnea in the otherwise healthy, term newborn: national prevalence and utilization during the birth hospitalization. J Pediatr. 2017; 181: 67–73.e1.
  30. Patrinos ME, Martin RJ. Apnea in the term infant. Semin Fetal Neonatal Med. 2017; 22(4): 240–244.
  31. Ramanathan R, Corwin MJ, Hunt CE, et al. Collaborative Home Infant Monitoring Evaluation (CHIME) Study Group. Cardiorespiratory events recorded on home monitors: comparison of healthy infants with those at increased risk for SIDS. JAMA. 2001; 285(17): 2199–2207.
  32. Liu D, Armitstead J, Benjafield A, et al. Trajectories of emergent central sleep apnea during CPAP therapy. Chest. 2017; 152(4): 751–760.
  33. Kalaydzhiev P, Poroyliev N, Somleva D, et al. Sleep apnea in patients with exacerbated heart failure and overweight. Sleep Med X. 2023; 5: 100065.
  34. Arzt M, Floras JS, Logan AG, et al. CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the canadian continuous positive airway pressure for patients with central sleep apnea and heart failure trial (CANPAP). Circulation. 2007; 115(25): 3173–3180.
  35. Dark D, Pingleton S, Kerby G, et al. Breathing pattern abnormalities and arterial oxygen desaturation during sleep in the congestive heart failure syndrome. Chest. 1987; 91(6): 833–836.
  36. Naughton MT, Benard DC, Rutherford R, et al. Effect of continuous positive airway pressure on central sleep apnea and nocturnal PCO2 in heart failure. Am J Respir Crit Care Med. 1994; 150(6): 1598–1604.
  37. Jilek C, Krenn M, Sebah D, et al. Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study. Eur J Heart Fail. 2011; 13(1): 68–75.
  38. Sasayama S, Izumi T, Seino Y, et al. CHF-HOT Study Group. Effects of nocturnal oxygen therapy on outcome measures in patients with chronic heart failure and cheyne-stokes respiration. Circ J. 2006; 70(1): 1–7.
  39. Schmickl CN, Landry S, Orr JE, et al. Effects of acetazolamide on control of breathing in sleep apnea patients: mechanistic insights using meta-analyses and physiological model simulations. Physiol Rep. 2021; 9(20): e15071.
  40. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med. 1996; 335(8): 562–567.
  41. Fischer R, Lang SM, Leitl M, et al. Theophylline and acetazolamide reduce sleep-disordered breathing at high altitude. Eur Respir J. 2004; 23(1): 47–52.
  42. DeBacker WA, Verbraecken J, Willemen M, et al. Central apnea index decreases after prolonged treatment with acetazolamide. Am J Respir Crit Care Med. 1995; 151(1): 87–91.